FindTrial
Sign In

Prospective, controlled pilot study for the use of non-contact perfusion and thermography measurements in patients with peripheral arterial disease, chronic venous insufficiency, or diabetes mellitus (with or without ulceration) compared to patients with spider vein varikosis

Prospective, controlled pilot study for the use of non-contact perfusion and thermography measurements in patients with peripheral arterial disease, chronic venous insufficiency, or diabetes mellitus (with or without ulceration) compared to patients with spider vein varikosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00013886
Enrollment
40
Registered
2018-01-30
Start date
2018-02-16
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory disorders in venous disease, arterial occlusive disease and diabetes mellitus in cf. to spider veins varicosis I87 I70.2 E13 I83.9

Interventions

Group 1: Non-contact perfusion and thermography measurements with Digital camera, Thermographiekamera, infrared camera, recording with Hyperspektralkamera in patients with peripheral arterial occlusiv

Sponsors

Phlebologisches Studienzentrum am Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: •Men and women • Age> 18 years • written consent • Possibility and will to participate • Known vascular disease of the legs in defined stages (CVI C3-C6 or PAD IIb-IV or diabetes mellitus with / without ulceration) or healthy leg vessels (spider veins / ret. Varices only) • No surgical or interventional treatment of the legs / leg vessels in the last 6 months

Exclusion criteria

Exclusion criteria: • Lack of consent • Lack of will or lack of opportunity to follow the examination protocol • Acute thrombosis of the arterial or venous leg vessels • Acute inflammation of the legs • Extensive scars on the legs after trauma • immobilization • Pregnancy, breastfeeding • Skin type IV to VI

Design outcomes

Primary

MeasureTime frame
The target parameters are the non-contact perfusion and thermography measurements at the time of the conclusion visit. Measured with: Infrared thermography: target parameters: 1. Spatially resolved measurement of the temperature in the wound region. 2. Shape and size of the wound. Near-infrared (PPGI): Target parameters: 1. Quantification of perfusion in the wound region. Canon camera: target parameters: 1.Shape, size and color of the wound. Hyperspectral camera: target parameters: 2. Quantification of wound region and environment perfusion by calculation of tissue oxygenation, near-infrared perfusion index, tissue hemoglobin index and tissue-water index of human tissue—

Secondary

MeasureTime frame
no secondary endpoints—

Countries

Germany

Contacts

Public ContactMarkus Stücker

Phlebologisches Studienzentrum am Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken

markus.stuecker@klinikum-bochum.de0234/8792-274

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026